Made available in DSpace on 2020-12-11T21:47:22Z (GMT). No. of bitstreams: 0 Previous issue date: 2020-05-01; Background: Rifaximin is an oral antimicrobial with a daily dose ranging from 600 to 800 mg. It is classified as Class IV in the Biopharmaceutic Classification System. Thus, rifaximin-based samples were developed by complexation to beta-cyclodextrin using a phase solubility diagram, and malaxation and d...
Made available in DSpace on 2019-10-06T16:18:52Z (GMT). No. of bitstreams: 0 Previous issue date: 2019-04-01; Rifaximin, an oral antimicrobial drug, is marketed as 200-mg tablets. The daily dose ranges from 600 mg (1 tablet 3 times a day) to 800 mg (2 tablets twice a day). It is used for a wide range of ages, from adults to children, since it is indicated for the treatment of hepatic encephalopathy, travelers’ ...
Objective: Analyze the information contained in homozygous haplotypes detected with high density genotyping. Methods: We analyze the genotypes of ∼2,500 markers on chr 22 in 12 population samples, each including 200 individuals. We develop a measure of disequilibrium based on haplotype homozygosity and an algorithm to identify genomic segments characterized by non-random homozygosity (NRH), taking into account ...